Information For Authors

1. Author Guidelines / Instructions to Authors

1.1 Summary

The Journal  endeavours to publish unbiased content. All articles must be of an impartial nature.

Invited contributors are assessed by the Editor-in-Chief with the support of the Section Editors, and guidance from the Editorial Board. Following acceptance of an invitation, the authors and Managing Editor, in conjunction with the Editor-in-Chief, formalise the working title and scope of the article.

We consider uninvited submissions provided they meet our publication criteria.

Following submission, articles are subject to independent double-blind peer review and copy editing prior to publication. All articles must receive final approval of the Editor-in-Chief and/or Section Editors before they are published.

Articles must be submitted using our electronic peer review system, Editorial Manager. Please select the relevant Journal below to submit a paper:

Arrhythmia and Electrophysiology Review (AER)

Cardiac Failure Review (CFR)

European Cardiology Review (ECR)

Interventional Cardiology Review (ICR)

US Cardiology Review (USC)  

Vascular and Endovascular Review (VER) 

If you are interested in submitting a manuscript and wish to discuss it further, or have any editorial queries please contact the Managing Editor for the Journal: ashlynne.merrifield@radcliffe-group.com for AER, ECR, and ICR or rosie.scott@radcliffe-group.com for CFR, USC and VER. 

1.2 Authorship Criteria

All authors involved should be listed and are accountable for the content should it be published and must meet the following conditions to be considered an author:

  1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  2. Drafting the work or revising it critically for important intellectual content; AND
  3. Final approval of the version to be published; AND
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Those meeting the above criteria are eligible to participate in reviewing and drafting the final manuscript. The corresponding author will be responsible for key communication with Publisher. Those not meeting the above criteria should be acknowledged as a ‘Contributor’ in the ‘Acknowledgments’ section rather than an author. The editor is not held responsible for identifying authors on the manuscript. This information must be supplied at submission.

1.3 Submission Types

Articles accepted for publication include the following content types and may be solicited or unsolicited:

Content Type

Description

Keywords

Word limits (excluding references/abstract)

Misc.

Figs

Tables

Videos

Clinical perspectives

Accepted in journals?

Case report

Present novel findings or strategies on a particular topic to aid diagnosis/treatment/management

7

1500 – 3000

Max. 50 refs

Abstract to be supplied (120-160 words)

VER

300dpi

Max. 5

tif,.pdf or .jpeg format

Editorial

An article that reflects on a particular issue, event, methodology, innovation or gap in literature.

7

1500 – 2000

Max. 15 refs

Not subject to peer-review)

 

 

All Journals

300dpi

Max. 5

tif,.pdf or .jpeg format

Expert opinion

Coverage of topical issues in cardiology from expert in field that will be of interest to readers

7

1500 – 2500

Max. 20 refs

Accompanied by an abstract (120-160 words)

All Journals

300dpi

Max. 5

tif,.pdf or .jpeg format

Letter to editor

Readers are invited to provide comment on articles for the EiC to read/respond.

7

1500

Max. 10 refs

Not subject to peer-review

All Journals

Review article

Summary and critical evaluation of current research in field and impact on current and future practice.

7

2500 – 5000

Max. 80 refs

Accompanied by an abstract (120-160 words)

Required in VER and AER, optional for others

All Journals

300dpi

Max. 5

tif,.pdf or .jpeg

1.4 Article preparation – Checklist Summary

Section

Requirement

Submission Types

  • Case Reports: 1,500 3,000 words excl abstract & refs. Max. 50 references.

  • Editorial: 1500-2000 words excl abstract & refs. Max 15 references.

  • Expert Opinion: 1,500 – 2500 words excl abstract & ref. Max. 20 references

  • Letter: 1500 words. Max 10 references.

  • Review Article: 2,500 – 5,000 words excl abstract & ref. Max. 80 references.

Manuscript

Submitted as word doc

Continuous line numbering

Double spacing

Page numbers

Title Page

Title: of the article (<300 characters);

Short title (<75 characters);

Author(s) information: full name, position, institution and/or organization, full contact information: email addresses for all authors and a postal correspondence address for the lead author. We also encourage ORCID identification to be listed.

Disclaimers: a statement of disclosure/conflicts of interest relevant to the article for each author; form for Disclosure of Potential Conflicts of Interest: www.icmje.org/conflicts-of-interest

Support statements: include grants, equipment, drugs, and /or other support that facilitated conduct of the work

Keywords: a maximum of 7 keywords to be listed

Word count: should be provided for the article and should not include the abstract

Abstract

Provides the context of the article. Should summarise the purpose, basic procedure, main findings and key conclusions.

<300 words Article, <120 words Expert opinion

Unstructured, unreferenced

Keywords

7

Clinical Perspective

Summarising the clinical implications of your review in three to five bullet points.

Acknowledgements

The author(s) should acknowledge substantive contributions to the article, including assistance, advice, materials and other resources.

Conflicts of interest/Disclosures

The author(s) should state any conflicts of interest/intellectual property to the article, including any sources of financial support or assistance for work; ensure sponsor names are included if applicable.

Ensure to highlight if authors had access to the study data.

If a funded paper, please include the statement: Authors had full access to all data in this study and take full responsibility for the integrity of the data and the accuracy of the data analysis.

Informed Consent

Authors should include a statement in the manuscript that informed consent was obtained, if experimentation with human subjects was conducted. The privacy rights of human subjects must always be observed. 

Layout

Divide the text under headings and subheadings. Keep these short and succinct (max 5 words) and similar in sense and style.

Language

All articles should be written in UK English, free from jargon, and the writing should be clear and direct. [note: USC Journal uses US SPELLING].

 All acronyms and abbreviations must be explained in full at first mention.

Figures, Tables, illustrations, screenshots and photographs

A maximum of five may be included. Anything over this amount should be supplied as supplementary data.

Figures must be supplied as digital files only (.tiff, .pdf or .jpeg files) and be at least 300 dpi.

Clear and concise titles/captions must be provided, and all symbols and abbreviations used must be defined in a footnote.

All figures must be referred to in the main text.

Figure and table legends must be included in the manuscript after the reference section

All abbreviations in figures must be spelled out in full in the figure caption.

High resolution images to be provided at revision stages if not supplied at submission.

Tables:

Graphs and tables must be supplied as editable files formatted as a table in Microsoft Word or Excel.

To be added after the reference list.

Authors are responsible for obtaining permission for all copyright material, including tables, figures and images. Please provide licences with submission.

References

In text: All articles must be fully referenced

References must be numbered in order of first mention. They must be indicated in the text by a superscript number with the full list at the end of the article in numerical/chronological order. include the first three authors only. Authors must include DOI and Pub Med ID. (Pub Med IDs can often be imported simply and quickly using a software such as EndNote which most institutions have access to).

Examples: 

Journal article: Delpón E, Cordeiro JM, Núñez L, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2008;1:209–18. https://doi.org/10.1161/CIRCEP.107.748103; PMID: 19122847.

Book Chapter: Mansbach H. Sumatriptan: looking back and looking forward. In: Humphrey P, Ferari M and Olesen J (eds ), The Triptans. New York: Oxford University Press, 2001;183–9.

Permissions

Authors are responsible for obtaining permission for all copyright material, including tables, figures and images. Permission is required irrespective of ownership. Permission proof is required at the time of submission. Papers cannot be accepted for publication until all necessary permissions are obtained.

1.5 Article Preparation – in detail

Articles should be supplied in Microsoft Word, with all pages clearly numbered. The work should not be already submitted for consideration elsewhere nor have been previously published.

Title Page – Should include the title of the article; author(s)’ full name, position and institution; an abstract and key words; any relevant conflicts of interest; corresponding address; and article word count (excluding references).

Article Length – Each article type has its own word limit. Articles submitted with word counts exceeding the limit will either be returned for reduction by the author or be reduced in length by the Editor. Please refer to table above for guidance on word limits based on content type.

Layout – Use headings within the text to make it easier to read and understand. Subdivide the text into main sections with subheadings. Keep these short and succinct and similar in sense and style.

Language – All articles should be written in UK English, free from jargon, and the writing should be clear and direct. All acronyms and abbreviations must be explained in full at first mention. We use UK spelling (unless the submission if for US Cardiology Review where US spelling is followed).

Figures – Tables, illustrations, screenshots and photographs – A maximum of six may be used. Anything above this number should be supplied as supplementary data. These are welcome where they add emphasis, clarity and/or interest to articles and should be clearly labelled with relevant captions. They must be referred to in the main text and numbered sequentially. All symbols and abbreviations used in figures must be defined.

Illustrations – Digital files must be saved as .tiff, .pdf or .jpeg format and be at least 300dpi. Original figures may be redrawn as necessary.

Videos – May be published in the online article with a still image of the video in the print file/PDF. Videos to be submitted in mp4 or avi format. Please ensure the video is accurately labelled. Any additional videos submitted but not included in the main article may appear as supplementary data.

Clinical Perspectives - if applicable to the content type please include a Clinical Perspective section at the end of the article, summarising the clinical implications of your review in two to five bullet points.

Supplementary data - Supplementary material may be submitted to the journal if they are necessary to the integrity and excellence of the manuscript and may take form of figures, tables, datasets, videos, slide sets, formulas, podcasts etc. Supplementary material must be submitted at the time of manuscript submission as a separate file and will be published as a pdf file (unless in audio or video format).

PLEASE NOTE: Supplementary material will be subject to the same peer-review standards as the manuscript but will not be edited by the Journal. Therefore, please take care to ensure that supplementary content is labelled and presented correctly, that grammar is corrected and that the journal style is followed throughout, especially in the references. Supplementary references must be cited in the main article and referenced at the end of the manuscript / acknowledgements.

1.6 Permissions

If a figure, table or illustration has been previously published, please ensure the original source is acknowledged as a figure legend and written permission from the copyright holder is sought.

If it is data taken from and no permissions are required – Data from: XXX et al. YEAR,RefXXX et al. YEAR,RefXXX et al. YEAR.Ref
If it is reproduced – Source: XXX et al. YEAR.Ref Reproduced with permission from PUBLISHER.
If it is adapted – Source: XXX et al. YEAR.Ref Adapted with permission from PUBLISHER.

Original images that are the authors own and that have not been published elsewhere, do not require permission. If applicable, please indicate this as a legend in your submission. If all images are original, please include a statement to this effect in the manuscript/at submission.

Our journals are open access. Please ensure that Open Access re-use permission is sought where possible. If it if not, please highlight this by adding ‘This content is not covered by the Creative Commons license of this publication. To re-use please contact the rights holder.’

Authors are responsible for obtaining permission for all copyright material, including tables, figures and images. Permission is required irrespective of ownership. Permission proof is required at the time of submission. Papers cannot be accepted for publication until all necessary permissions are sought.

1.7 Declarations: Conflict of interest of interest/Intellectual Property

A conflict of interest exists when an opinion may be influenced or biased by a secondary interest such as financial gain. Conflicts of interest may occur from commercial or financial interests and/or personal relationships, beliefs and or rivalries such as research funding, consultancy services, serving on speakers’ bureaus, travel expenses, appearance fees, the receipt of share options, or direct employment by a commercial entity. All author’s, peer reviewers and editors must declare any conflicts of interest pertaining to the article when submitting a manuscript. All sources of support for the work where a conflict exists will be publicized. Conversely, please state clearly should there be no conflicts of interest to declare.

Authors must complete the questions asked in our electronic submission system (Editorial Manager), which follow the ICMJE recommendations. These answers will be stored, and a disclosure statement will appear on every manuscript published within the journal based on your response. The purpose of this statement is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. For more information and to download a Form for Disclosure of Potential Conflicts of Interest, which can be submitted with your manuscript, please visit: www.icmje.org/conflicts-of-interest/

Reviewers must declare any conflicts of interest before conducting a peer review of a manuscript. Reviewers should decline to review if a potential conflict of interest is present.

Editorial staff employed by Radcliffe Group, Editor’s in Chief and Guest Editors, will not handle manuscripts where a potential conflict of interest exists.

Acknowledgements – The author(s) should acknowledge substantive contributions to the article, including receipt of financial assistance, materials and other resources.

Informed Consent – Authors should include a statement in the manuscript that informed consent was obtained, if experimentation with human subjects was conducted. The privacy rights of human subjects must always be observed. For more information please read: http://www.radcliffecardiology.com/privacy-statement

Human and Animal Rights – If the work involves the use of animal or human subjects, the author should ensure that the work described has been carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for research involving humans http://www.wma.net/en/30publications/10policies/b3/index.html or the EU Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm

1.8 References

All articles must be fully referenced. References must be numbered in order of first mention. They must be indicated in the text by a number with the full list at the end of the article in numerical order. They must not be used to promote self-interests.

Journal Articles

Journal abbreviations are used as per Medline. Include the first three authors only. Details should be ordered as: Surname Initials. Article title. Journal name year;volume:page numbers. doi: [doi number}. PMID: [PMID number}.

Example: Delpón E, Cordeiro JM, Núñez L, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2008;1:209–18. https://doi.org/10.1161/CIRCEP.107.748103; PMID: 19122847.

Book Chapters

Mansbach H. Sumatriptan: looking back and looking forward. In: Humphrey P, Ferari M, Olesen J (eds). The Triptans. New York: Oxford University Press, 2001;183–9.

2. Peer Review Process

On submission, items submitted to the journal are assessed by the Editor in Chief to assess their suitability for inclusion. Items that are deemed unsuitable, fail a technical check or that are deemed more suitable for another journal are returned at this stage.

The Managing Editor/Review Editor, following consultation with the Editor-in-Chief, Section Editors and/or a member of the Editorial Board, sends the manuscript for peer review. All peer review is conducted independently and is double-blinded. The peer reviewers are selected on the basis of their expertise in the article subject matter. Peer reviewers are not part of the editorial staff and are independent from the article.

The peer review feedback is used to critically assess the quality of the article, to assess its suitability for inclusion in the Journal and to ensure its credibility of scientific information.

Following review, manuscripts are either accepted without modification, accepted pending modification, or may require further revision, in which case the manuscripts may be returned to the author(s) to incorporate required changes, or may be rejected outright. Not all articles that are revised are subsequently accepted. The Editor-in-Chief reserves the right to accept or reject any proposed amendments.

Once the authors have revised a manuscript in accordance with the reviewers’ comments, the manuscript is returned to the reviewers to ensure the revised version meets their quality expectations. Once approved, the manuscript is sent to the Editor-in-Chief for final approval prior to publication. We aim to complete the peer review process and the average time to first decision within 12-weeks.

It is our aim to ensure authors are notified of any rejection or retraction as soon as possible. An editor can reject an article at any time before publication, including after acceptance if there are concerns over the work.

In the event that a journal is no longer published, access to all articles will be available via alternative indexes such as PubMed Central/ESCI/Scopus.

3. Manuscript Acceptance

3.1 Proofs

All accepted manuscripts will be subject to editorial revisions for clarity, punctuation, syntax and conformity to house style.

Laid out proofs will be sent to the corresponding author following the first stage of editing. Any requests for changes must be returned by the deadline given. Articles are considered final once an author approves the corrected proofs. Only minor changes can be made at the proofing stage; major changes will not be accepted.

4. Information for Authors

4.1 Copyright, Permissions and Open Access

As of 2019, articles published in our Journals are open access, which means content is freely available without charge and allows users to read, download, copy, redistribute and make derivative works for non-commerical purposes, provided the original work is cited correctly. The author retains all non-commerical rights for articles published under the CC-BY-NC 4.0 license.

Radcliffe Medical Media retains all commercial rights for articles herein unless otherwise stated. Permission to reproduce an article or any of its contents for commercial purposes, either in full or in part, should be sought from the publication's Managing Editor.

Authors are responsible for obtaining permission for all copyright material, including tables, figures and images. Evidence will need to be provided for all permissions granted.

4.2 Author Fees

To support open access publication costs, Radcliffe Cardiology and Radcliffe Vascular charge an Article Publication Charge (APC) to authors upon acceptance of an unsolicited paper as follows:

Content type

Fee

Indexed Journal (PubMed/Scopus/ESCI)

Non-indexed Journal

Article

£1,050 | €1,200 | $1369

No fee

Case Report

£787 | €870 | $970

No fee

Editorial

No fee

No fee

Expert Opinion

£787 | €870 | $970

No fee

Letter

No fee

No fee

Meta-Analysis

£787 | €870 | $970

No fee

Submissions from the UK will be subject to VAT. A VAT registration number should be supplied if applicable. If you are not registered for VAT, your invoice will still have VAT added.

After manuscript acceptance, the corresponding author will be contacted, and an invoice will be sent.

4.2.1 APC Waivers and Discounts

A 100% waiver is applicable under the following circumstances:

  • For all content solicited by Radcliffe Cardiology/Radcliffe Vascular.
  • For all unsolicited content submitted to a non-indexed journal.
  • For all letters and editorials submitted to the journal.
  • For all content submitted by an Editorial Board member.
  • If the corresponding author is from a low-income country (as defined by the World Bank).

A 50% waiver is applicable under the following circumstances:

  • If the corresponding author is from a middle-income country (as defined by the World Bank).

Discretionary waivers may also be considered.

Radcliffe Cardiology/Radcliffe Vascular remains dedicated to helping researchers to disseminate scientific information globally and is working to partner with individual institutions to offer full or partial APC discounts. If you are an institution looking to partner with us, or think your institution should, then please contact the Publishing Director.

To ensure editorial integrity, the waiver process is not handled by the journal Managing Editors.  Authors should submit a waiver request during the electronic submission process.

4.3 Misconduct

Radcliffe Cardiology/Radcliffe Vascular takes reasonable steps to identify and prevent research misconduct. Our journals use similarity checking software to detect unoriginal material. Where duplication is highlighted, the concerns will be raised with the authors. Papers suspected of unattributed copying or misconduct will not be considered for publication. We reserve the right to inform author’s institutions when such instances occur.

4.4 Errors and Omissions

Radcliffe Cardiology/Radcliffe Vascular will take every care possible to try to ensure that all content is reproduced correctly. However, we cannot guarantee the accuracy, adequacy or completeness of any information and cannot be held responsible for any errors or omissions, or for the results obtained from the use thereof. Errata are issued as needed and any errors should be reported to the Journal’s Managing Editor.

4.5 Advertising

Advertising is not permitted to influence editorial decisions. Advertisements cannot be carried by the journal that juxtapose editorial content on the same product. Adverts may appear at the front and back of a journal (never within text).

4.6 Complaints and Appeals

Any complaints should be first directed to the Managing Editor of the Journal. If they are the subject of the complaint, please raise this with the Publishing Director.

4.7 Reprints

Reprints of all published articles are available to authors, institutions and commercial organisations. Please contact Rob Barclay at rob.barclay@radcliffe-group.com

4.8 Data Sharing

For information on our data sharing policy please click here.